5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats (Q44264971)

1 December 2017

title

5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats (English)

1 reference

1 December 2017

0 references

Doreen Awabdy

1 reference

1 December 2017

Lesley J Bryan-Lluka

series ordinal

1 reference

1 December 2017

Janet C Wanstall

series ordinal

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

European Journal of Pharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

459

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

1-7

1 reference

Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

The role of thrombosis in severe pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Pulmonary hypertension and fenfluramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Increased plasma serotonin in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Specific uptake of 5-hydroxytryptamine is reduced in lungs from hypoxic pulmonary hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Reduced serotonin uptake by spontaneously hypertensive rat platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902734-6

10.1016/S0014-2999(02)02734-6

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference